Try our Advanced Search for more refined results

S&P Lowers Valeant Credit Rating After Delayed SEC Filing

By Vince Sullivan (April 14, 2016, 7:39 PM EDT) -- Standard & Poor's Ratings Services lowered the credit rating of Valeant Pharmaceuticals International Inc. Thursday, citing a default on $1 billion in notes triggered by the company's late filing with the U.S. Securities and Exchange Commission of its financial report for the 2015 fiscal year....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!